Gif sur Yvette, France

Eric Bacqué

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Bacqué. Retrieved from https://idiyas.com/inventor/eric-bacquandeacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eric Bacqué: Innovator in Antimicrobial Agents

Introduction

Eric Bacqué is a notable inventor based in Gif sur Yvette, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. With a total of two patents to his name, Bacqué's work has had a meaningful impact on medical science.

Latest Patents

Eric Bacqué's latest patents include "Quinolylpropylpiperidine derivatives, preparation process and intermediates" and "Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them." These derivatives, described by Bacqué, are useful as antimicrobial agents. The preparation processes for these compounds are also detailed in his patents, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Bacqué is associated with Aventis Pharma S.A., a prominent company in the pharmaceutical industry. His work at Aventis has allowed him to focus on the research and development of new medicinal compounds, contributing to advancements in healthcare.

Collaborations

Throughout his career, Eric Bacqué has collaborated with esteemed colleagues such as Serge Mignani and Jean-Luc Malleron. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the field of pharmaceuticals.

Conclusion

Eric Bacqué is a distinguished inventor whose work in antimicrobial agents has made a significant impact on the pharmaceutical industry. His patents reflect his dedication to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…